70mg Dyronib Dasatinib Tablets

Description

Dyronib 70 mg Tablets (Dasatinib) contain dasatinib, a targeted anticancer medicine used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by inhibiting abnormal proteins that signal cancer cells to grow, thereby slowing disease progression. The tablets are taken orally as prescribed by an oncologist, usually once or twice daily depending on the treatment plan. Dyronib helps control leukemia and improve treatment outcomes. It must be used under strict medical supervision due to possible side effects and required monitoring.